Cite
OATP1B3 Is Expressed in Pancreatic [beta]-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide.
MLA
Meyer Zu Schwabedissen, Henriette E., et al. “OATP1B3 Is Expressed in Pancreatic [Beta]-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide.” Diabetes, vol. 63, no. 2, Feb. 2014, pp. 775–84. EBSCOhost, https://doi.org/10.2337/db13-1005.
APA
Meyer Zu Schwabedissen, H. E., Boettcher, K., Steiner, T., Schwarz, U. I., Keiser, M., Kroemer, H. K., & Siegmund, W. (2014). OATP1B3 Is Expressed in Pancreatic [beta]-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide. Diabetes, 63(2), 775–784. https://doi.org/10.2337/db13-1005
Chicago
Meyer Zu Schwabedissen, Henriette E, Kerstin Boettcher, Tobias Steiner, Ute I Schwarz, Markus Keiser, Heyo K Kroemer, and Werner Siegmund. 2014. “OATP1B3 Is Expressed in Pancreatic [Beta]-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide.” Diabetes 63 (2): 775–84. doi:10.2337/db13-1005.